DTL
RNAM

Dynamic Technology Lab’s Avidity Biosciences RNAM Stock Holding History

Dynamic Technology Lab’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,830
Closed -$402K – 1294
2024
Q4 		$402K Buy
+13,830
New +$578K 0.06% 538
2024
Q1 		– Sell
-52,788
Closed -$478K – 1368
2023
Q4 		$478K Buy
52,788
+28,160
+114% +$188K 0.05% 606
2023
Q3 		$157K Buy
24,628
+85
+0.3% +$732 0.02% 823
2023
Q2 		$272K Buy
+24,543
New +$308K 0.03% 740
2022
Q3 		– Sell
-16,199
Closed -$235K – 1460
2022
Q2 		$235K Buy
+16,199
New +$241K 0.03% 865

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's RNAM Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Avidity Biosciences (RNAM) in Q1 2025, closing a stake of 13,830 shares — an estimated $402K sold.

Dynamic Technology Lab first reported a position in RNAM in Q2 2022 and held it in 5 quarters. The position peaked at $478K in Q4 2023. 220 funds tracked by Wall St. Rank hold RNAM as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Avidity Biosciences position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 13,830 Avidity Biosciences shares in Q1 2025, an estimated $402K.
  • Dynamic Technology Lab first reported a position in Avidity Biosciences in Q2 2022 and held it in 5 quarters.
  • Dynamic Technology Lab's Avidity Biosciences position peaked at $478K in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.